Health care utilization and costs by metabolic syndrome risk factors

D. M. Boudreau, Daniel C Malone, M. A. Raebel, P. A. Fishman, G. A. Nichols, A. C. Feldstein, A. N. Boscoe, R. H. Ben-Joseph, D. J. Magid, L. J. Okamoto

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Background: This study compared prevalent health utilization and costs for persons with and without metabolic syndrome and investigated the independent associations of the various factors that make up metabolic syndrome. Methods: Subjects were enrollees of three health plans who had all clinical measurements (blood pressure, fasting plasma glucose, body mass index, triglycerides, and high-density lipoprotein cholesterol) necessary to determine metabolic syndrome risk factors over the 2-year study period (n = 170,648). We used clinical values, International Classification of Diseases, Ninth Revision (ICD-9) diagnoses, and medication dispensings to identify risk factors. We report unadjusted mean annual utilization and modeled mean annual costs adjusting for age, sex, and co-morbidity. Results: Subjects with metabolic syndrome (n = 98,091) had higher utilization and costs compared to subjects with no metabolic syndrome (n = 72,557) overall, and when stratified by diabetes (P < 0.001). Average annual total costs between subjects with metabolic syndrome versus no metabolic syndrome differed by a magnitude of 1.6 overall ($5,732 vs. $3,581), and a magnitude of 1.3 when stratified by diabetes (diabetes, $7,896 vs. $6,038; no diabetes, $4,476 vs. $3,422). Overall, total costs increased by an average of 24% per additional risk factor (P < 0.001). Costs and utilization differed by risk factor clusters, but the more prevalent clusters were not necessarily the most costly. Costs for subjects with diabetes plus weight risk, dyslipidemia, and hypertension were almost double the costs for subjects with prediabetes plus similar risk factors ($8,067 vs. $4,638). Conclusions: Metabolic syndrome, number of risk factors, and specific combinations of risk factors are markers for high utilization and costs among patients receiving medical care. Diabetes and certain risk clusters are major drivers of utilization and costs.

Original languageEnglish (US)
Pages (from-to)305-313
Number of pages9
JournalMetabolic Syndrome and Related Disorders
Volume7
Issue number4
DOIs
StatePublished - Aug 1 2009

Fingerprint

Patient Acceptance of Health Care
Health Care Costs
Costs and Cost Analysis
International Classification of Diseases
Prediabetic State
Dyslipidemias
HDL Cholesterol
Fasting
Triglycerides
Body Mass Index
Blood Pressure
Hypertension
Morbidity

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Boudreau, D. M., Malone, D. C., Raebel, M. A., Fishman, P. A., Nichols, G. A., Feldstein, A. C., ... Okamoto, L. J. (2009). Health care utilization and costs by metabolic syndrome risk factors. Metabolic Syndrome and Related Disorders, 7(4), 305-313. https://doi.org/10.1089/met.2008.0070

Health care utilization and costs by metabolic syndrome risk factors. / Boudreau, D. M.; Malone, Daniel C; Raebel, M. A.; Fishman, P. A.; Nichols, G. A.; Feldstein, A. C.; Boscoe, A. N.; Ben-Joseph, R. H.; Magid, D. J.; Okamoto, L. J.

In: Metabolic Syndrome and Related Disorders, Vol. 7, No. 4, 01.08.2009, p. 305-313.

Research output: Contribution to journalArticle

Boudreau, DM, Malone, DC, Raebel, MA, Fishman, PA, Nichols, GA, Feldstein, AC, Boscoe, AN, Ben-Joseph, RH, Magid, DJ & Okamoto, LJ 2009, 'Health care utilization and costs by metabolic syndrome risk factors', Metabolic Syndrome and Related Disorders, vol. 7, no. 4, pp. 305-313. https://doi.org/10.1089/met.2008.0070
Boudreau, D. M. ; Malone, Daniel C ; Raebel, M. A. ; Fishman, P. A. ; Nichols, G. A. ; Feldstein, A. C. ; Boscoe, A. N. ; Ben-Joseph, R. H. ; Magid, D. J. ; Okamoto, L. J. / Health care utilization and costs by metabolic syndrome risk factors. In: Metabolic Syndrome and Related Disorders. 2009 ; Vol. 7, No. 4. pp. 305-313.
@article{a8dfc74592b64796af073c092aee2eea,
title = "Health care utilization and costs by metabolic syndrome risk factors",
abstract = "Background: This study compared prevalent health utilization and costs for persons with and without metabolic syndrome and investigated the independent associations of the various factors that make up metabolic syndrome. Methods: Subjects were enrollees of three health plans who had all clinical measurements (blood pressure, fasting plasma glucose, body mass index, triglycerides, and high-density lipoprotein cholesterol) necessary to determine metabolic syndrome risk factors over the 2-year study period (n = 170,648). We used clinical values, International Classification of Diseases, Ninth Revision (ICD-9) diagnoses, and medication dispensings to identify risk factors. We report unadjusted mean annual utilization and modeled mean annual costs adjusting for age, sex, and co-morbidity. Results: Subjects with metabolic syndrome (n = 98,091) had higher utilization and costs compared to subjects with no metabolic syndrome (n = 72,557) overall, and when stratified by diabetes (P < 0.001). Average annual total costs between subjects with metabolic syndrome versus no metabolic syndrome differed by a magnitude of 1.6 overall ($5,732 vs. $3,581), and a magnitude of 1.3 when stratified by diabetes (diabetes, $7,896 vs. $6,038; no diabetes, $4,476 vs. $3,422). Overall, total costs increased by an average of 24{\%} per additional risk factor (P < 0.001). Costs and utilization differed by risk factor clusters, but the more prevalent clusters were not necessarily the most costly. Costs for subjects with diabetes plus weight risk, dyslipidemia, and hypertension were almost double the costs for subjects with prediabetes plus similar risk factors ($8,067 vs. $4,638). Conclusions: Metabolic syndrome, number of risk factors, and specific combinations of risk factors are markers for high utilization and costs among patients receiving medical care. Diabetes and certain risk clusters are major drivers of utilization and costs.",
author = "Boudreau, {D. M.} and Malone, {Daniel C} and Raebel, {M. A.} and Fishman, {P. A.} and Nichols, {G. A.} and Feldstein, {A. C.} and Boscoe, {A. N.} and Ben-Joseph, {R. H.} and Magid, {D. J.} and Okamoto, {L. J.}",
year = "2009",
month = "8",
day = "1",
doi = "10.1089/met.2008.0070",
language = "English (US)",
volume = "7",
pages = "305--313",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Health care utilization and costs by metabolic syndrome risk factors

AU - Boudreau, D. M.

AU - Malone, Daniel C

AU - Raebel, M. A.

AU - Fishman, P. A.

AU - Nichols, G. A.

AU - Feldstein, A. C.

AU - Boscoe, A. N.

AU - Ben-Joseph, R. H.

AU - Magid, D. J.

AU - Okamoto, L. J.

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Background: This study compared prevalent health utilization and costs for persons with and without metabolic syndrome and investigated the independent associations of the various factors that make up metabolic syndrome. Methods: Subjects were enrollees of three health plans who had all clinical measurements (blood pressure, fasting plasma glucose, body mass index, triglycerides, and high-density lipoprotein cholesterol) necessary to determine metabolic syndrome risk factors over the 2-year study period (n = 170,648). We used clinical values, International Classification of Diseases, Ninth Revision (ICD-9) diagnoses, and medication dispensings to identify risk factors. We report unadjusted mean annual utilization and modeled mean annual costs adjusting for age, sex, and co-morbidity. Results: Subjects with metabolic syndrome (n = 98,091) had higher utilization and costs compared to subjects with no metabolic syndrome (n = 72,557) overall, and when stratified by diabetes (P < 0.001). Average annual total costs between subjects with metabolic syndrome versus no metabolic syndrome differed by a magnitude of 1.6 overall ($5,732 vs. $3,581), and a magnitude of 1.3 when stratified by diabetes (diabetes, $7,896 vs. $6,038; no diabetes, $4,476 vs. $3,422). Overall, total costs increased by an average of 24% per additional risk factor (P < 0.001). Costs and utilization differed by risk factor clusters, but the more prevalent clusters were not necessarily the most costly. Costs for subjects with diabetes plus weight risk, dyslipidemia, and hypertension were almost double the costs for subjects with prediabetes plus similar risk factors ($8,067 vs. $4,638). Conclusions: Metabolic syndrome, number of risk factors, and specific combinations of risk factors are markers for high utilization and costs among patients receiving medical care. Diabetes and certain risk clusters are major drivers of utilization and costs.

AB - Background: This study compared prevalent health utilization and costs for persons with and without metabolic syndrome and investigated the independent associations of the various factors that make up metabolic syndrome. Methods: Subjects were enrollees of three health plans who had all clinical measurements (blood pressure, fasting plasma glucose, body mass index, triglycerides, and high-density lipoprotein cholesterol) necessary to determine metabolic syndrome risk factors over the 2-year study period (n = 170,648). We used clinical values, International Classification of Diseases, Ninth Revision (ICD-9) diagnoses, and medication dispensings to identify risk factors. We report unadjusted mean annual utilization and modeled mean annual costs adjusting for age, sex, and co-morbidity. Results: Subjects with metabolic syndrome (n = 98,091) had higher utilization and costs compared to subjects with no metabolic syndrome (n = 72,557) overall, and when stratified by diabetes (P < 0.001). Average annual total costs between subjects with metabolic syndrome versus no metabolic syndrome differed by a magnitude of 1.6 overall ($5,732 vs. $3,581), and a magnitude of 1.3 when stratified by diabetes (diabetes, $7,896 vs. $6,038; no diabetes, $4,476 vs. $3,422). Overall, total costs increased by an average of 24% per additional risk factor (P < 0.001). Costs and utilization differed by risk factor clusters, but the more prevalent clusters were not necessarily the most costly. Costs for subjects with diabetes plus weight risk, dyslipidemia, and hypertension were almost double the costs for subjects with prediabetes plus similar risk factors ($8,067 vs. $4,638). Conclusions: Metabolic syndrome, number of risk factors, and specific combinations of risk factors are markers for high utilization and costs among patients receiving medical care. Diabetes and certain risk clusters are major drivers of utilization and costs.

UR - http://www.scopus.com/inward/record.url?scp=68549085226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68549085226&partnerID=8YFLogxK

U2 - 10.1089/met.2008.0070

DO - 10.1089/met.2008.0070

M3 - Article

C2 - 19558267

AN - SCOPUS:68549085226

VL - 7

SP - 305

EP - 313

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

IS - 4

ER -